Updated Jul 16, 2026
Hallal David has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $3.97M.
David Hallal is the Chief Executive Officer of Scholar Rock Holding Corp, a biopharmaceutical company focused on innovative medicines. He has also held leadership roles in other healthcare companies, contributing to advancements in drug development.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Links | Wikipedia |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-20 | SRRK | Scholar Rock Holding Corp | S — Open-market sale | 30.6K | $49.57 | $1.52M |
| 2026-02-11 | SRRK | Scholar Rock Holding Corp | A — Grant or award | 128.0K | $0.00 | |
| 2026-01-16 | SRRK | Scholar Rock Holding Corp | S — Open-market sale | 57.5K | $42.70 | $2.45M |
| 2025-10-08 | SRRK | Scholar Rock Holding Corp | G — Bona-fide gift | 205.0K | $0.00 |
David Hallal is the Chief Executive Officer of Scholar Rock Holding Corp, a biopharmaceutical company focused on innovative medicines. He has also held leadership roles in other healthcare companies, contributing to advancements in drug development.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($3.97M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hallal David profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.